Influence of Postsynthetic Ligand Exchange in ZIF‑7 on Gate-Opening Pressure and CO₂/CH₄ Mixture Separation by Lukas W. Bingel (9371686)

Subjects:

Influence of Postsynthetic Ligand Exchange in ZIF‑7 on Gate-Opening Pressure and CO₂/CH₄ Mixture Separation by Lukas W. Bingel (9371686)

Subjects:

Species counts for all trap (kubben) catches across sites and seasons. by Maryann S. Watson (16879881)

Average Gait Speed (A), Cadence (B), Step Length (C), and Walk Ratio (D) across Terrains; Violin plots with individual participant data of A) gait speed, B) cadence, C) average ste... by Benjamin S. Killen (22766029)

Changes in the eGFRs and serum potassium levels compared with values at the end of 1 month of treatment in all patients over time. by Jia Song (495396)

Data Sheet 1_Ribosomal protein L9 is a potential therapeutic target for B-ALL through the activation of the p53 signaling pathway.docx by Xinxin Li (281237)

“…In this study, we observed a significant upregulation of RPL9 in human B-ALL cells compared to normal B cells, suggesting RPL9’s potential key role in B-ALL progression. …”

(A) Procedural steps for minimally invasive Ponto surgery (MIPS). The MIPS procedure involves the following steps: (i) A circular incision is created at the selected site via a 4-... by Marsel Ganeyev (21453399)

Subjects:

<i>Aedes aegypti</i> database from SAGO traps. by Jesús A. Aguilar-Durán (9931967)

“…<i><i>Aegypti</i></i> comparing female abundance between pre-treatment (10 weeks) and post-treatment (9 weeks) periods.</p><p>Results</p><p>All treatments were effective in significantly reducing <i><i>Ae</i></i>. …”

New visits, types of health events, procedure, and outcome of health events during all of 2020, and during the BR-period, Ramadan period, and AR-period. by Taizo Sakata (21567847)

Table 1_Gender difference in the association between composite dietary antioxidant index and all-cause mortality.docx by Lanzhi Duan (15350413)

“…The restricted cubic spline revealed that the hazard ratio (HR) of all-cause mortality decreased significantly with increasing CDAI. …”

Flow chart of participants selection. by Linjia Duan (13276989)

“…</p><p>Conclusions</p><p>Among older adults with cognitive impairment in China, the risk of all-cause mortality significantly decreased as both the frequency and number of cognitive activities increased. …”

Structural equation models raw data. by K. Kanoho Hosoda (19929050)

“…Giving kindness was significantly associated with decreased stress reduction and decreased institutional identity. …”

Summary of sample descriptive statistics. by K. Kanoho Hosoda (19929050)

“…Giving kindness was significantly associated with decreased stress reduction and decreased institutional identity. …”

CONSORT of participants with OPV status. by Zahid Hasan Khan (6281396)

“…Therefore, completion of all doses is crucial for achieving the best possible immunity. …”

Determinants of incomplete vaccination. by Zahid Hasan Khan (6281396)

“…Therefore, completion of all doses is crucial for achieving the best possible immunity. …”

Table 2_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

“…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I² = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I² = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I² = 65.5%). …”

Table 1_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

“…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I² = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I² = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I² = 65.5%). …”

Table 3_To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure.docx by Jinyu He (19774641)

“…Compared to conventional therapy or placebo, treatment with MRAs significantly reduced the risk of all-cause mortality (RR = 0.862, 95% CI: 0.778–0.956, p = 0.005; I² = 36.1%), cardiovascular mortality (RR = 0.828, 95% CI: 0.732–0.937, p = 0.003; I² = 45.7%), and heart failure-related hospitalization (RR = 0.780, 95% CI: 0.657–0.926, p = 0.005; I² = 65.5%). …”

Table 1_Association between oxidative balance score and all-cause and cancer-specific mortality among cancer survivors.pdf by Qingmei Gao (20905781)

“…In the context of all-cause mortality, the risk of death was found to be significantly lower in quartiles Q2, Q3 and Q4 when compared to the OBS in quartile Q1. …”

Table 1_Inflammation and nutritional status in relation to mortality risk from cardio-cerebrovascular events: evidence from NHANES.docx by Chengzhi Hou (20419865)

“…The higher levels of ALI and serum albumin were significantly associated with lower risks of all-cause and cardiovascular mortality among these individuals. …”